Clarification on Expected Behaviour for Data Quality Rules on Standalone Data Assets and Data Products

Anitha Ganesan 0 Reputation points
2026-07-16T15:02:14.84+00:00

Hi Microsoft Team,

We are seeking clarification on the intended behaviour of Microsoft Purview Data Quality when using standalone Data Assets and Data Products.

We have reviewed the following Microsoft documentation:

From our understanding of the documentation, a standalone Data Asset can be profiled, have Data Quality (DQ) rules configured, and then be associated with one or more Data Products. The documentation also states that the associated Data Product can reuse the Data Quality rules and quality scores created for the standalone asset.

We would like to confirm whether this is the intended product behaviour.

During our UAT testing, we tested the following scenario:

  1. Registered and scanned a Data Asset into the Data Map.
  2. Added the Data Asset to a Governance Domain as a standalone Data Asset.
  3. Ran profiling and configured Data Quality rules on the standalone Data Asset.
  4. Executed the profiling and Data Quality scans successfully on the standalone Data Asset.
  5. Associated the standalone Data Asset with a Data Product.

However, after associating the standalone Data Asset with the Data Product, we observed inconsistent behaviour, including:

  • Data Quality rules appeared as duplicate entries within the Data Product.
  • In some cases, duplicate rule entries appeared without associated quality scores.
  • Profiling statistics that were available on the standalone Data Asset were not visible after the asset was associated with the Data Product.
  • After rerunning Data Quality scans within the Data Product context, additional duplicate rule entries were intermittently observed, resulting in multiple instances of the same rule.

Could you please clarify the following?

  1. Is the intended design that Data Quality rules, profiling results, and quality scores configured on a standalone Data Asset are automatically reused when that asset is associated with one or more Data Products (including when the same asset is associated with multiple Data Products)?
  2. The behaviour we observed during UAT differed from our understanding of the documentation (duplicate rules, missing profiling statistics, missing quality scores, and additional duplicate rule entries after rerunning scans). Are these known issues, expected behaviour, or product limitations? If not, what is the recommended approach for this scenario?

If there are any recommended practices, known fixes, or documentation covering this scenario, we would appreciate your guidance.

Thank you for your assistance.

Microsoft Security | Microsoft Purview

1 answer

Sort by: Most helpful
  1. Sina Salam 31,296 Reputation points Volunteer Moderator
    2026-07-18T15:16:23.28+00:00

    Hello Anitha Ganesan,

    Welcome to the Microsoft Q&A and thank you for posting your questions here.

    I understand that you will need clarification on Expected Behaviour for Data Quality Rules on Standalone Data Assets and Data Products.

    In a normal circumstances standalone asset’s Data Quality rules, profiling results, and score should not be treated as a live synchronized result set across every Data Product. - https://learn.microsoft.com/en-us/purview/unified-catalog-data-quality-scan-asset The duplicate rules, missing scores, and missing profiling statistics are not a confirmed expected final state. They are most likely caused by stale Data Product asset metadata, duplicate asset association, hierarchy expansion when adding assets, or a backend product issue. - https://learn.microsoft.com/en-us/purview/data-governance-known-issues

    To resolve this, I will suggest you remove duplicate asset associations, refresh the asset in the Data Product, reimport schema if the source schema changed, run profiling in the Data Product context if profiling results are required there, and then run the Data Quality scan locally from that Data Product. Profiling and Data Quality scans are context-based operations in Purview Health Management, so the Data Product view should be validated from the Data Product’s own Data Quality page, not only from the standalone asset page. - https://learn.microsoft.com/en-us/purview/unified-catalog-data-quality-profiling. If duplicate rule rows or blank scores still appear after the above process, this should be treated as an unresolved product issue, not as expected behaviour. At that point, the correct next step for you is to open a Microsoft Support case via Azure Portal or contact priority customer support (PCS) with details. Microsoft Support or the Purview Product Group must then validate the backend metadata state. Use the associated links for more reading and steps.

    I hope this is helpful. Please! Do not hesitate to let me know if you have any other questions, steps or clarifications.


    Please do not close the thread by upvoting and accepting the answer if any part of it is helpful.

    Was this answer helpful?

    1 person found this answer helpful.

Your answer

Answers can be marked as 'Accepted' by the question author and 'Recommended' by moderators, which helps users know the answer solved the author's problem.